Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at SAR 34.3M, followed by Belite Bio (SAR 37.8M) and Oruka Therapeutics (SAR 62.6M). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsSAR 34.3M
- Median
- SAR 7.8B
- Combined market value
- SAR 19.08T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | SAR 34.3M | SAR 19.7B | SAR 467.94 | 0.71% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | SAR 37.8M | SAR 24.2B | SAR 597.01 | 0.91% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | SAR 62.6M | SAR 24.6B | SAR 362.53 | 0.34% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | SAR 113.8M | SAR 16.7B | SAR 152.96 | 3.00% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | SAR 140.7M | SAR 18.3B | SAR 324.22 | 0.63% down | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | SAR 200.6M | SAR 30.5B | SAR 467.60 | 0.01% down | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | SAR 224.2M | SAR 32B | SAR 1,145.48 | 0.10% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | SAR 234.6M | SAR 33.9B | SAR 356.80 | 1.40% up | 286% up | ||
| 9 | ErascaERAS · Health Care | SAR 266.3M | SAR 17.4B | SAR 49.70 | 4.61% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | SAR 346.3M | SAR 32.5B | SAR 40.70 | 1.69% up | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | SAR 404.3M | SAR 14.6B | SAR 106.87 | 3.03% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | SAR 537.4M | SAR 27.5B | SAR 313.75 | 1.88% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | SAR 708.4M | SAR 28.2B | SAR 257.56 | 2.01% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 735.3M | SAR 28.4B | SAR 361.00 | 1.19% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 788.3M | SAR 30.3B | SAR 437.69 | 0.06% up | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | SAR 1.1B | SAR 18.7B | SAR 107.29 | 2.71% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | SAR 1.6B | SAR 36.3B | SAR 240.40 | 2.20% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | SAR 1.6B | SAR 105.6B | SAR 145.69 | 0.34% up | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | SAR 1.8B | SAR 18.1B | SAR 188.71 | 1.55% down | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | SAR 2B | SAR 22.4B | SAR 343.54 | 0.40% down | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | SAR 2B | SAR 22.5B | SAR 1,124.34 | 2.02% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | SAR 2.3B | SAR 26.4B | SAR 501.10 | 1.74% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 2.5B | SAR 35.9B | SAR 1,544.77 | 2.41% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | SAR 2.5B | SAR 29.4B | SAR 175.02 | 2.66% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | SAR 2.7B | SAR 11.8B | SAR 60.82 | 0.65% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | SAR 2.9B | SAR 91.7B | SAR 2,154.26 | 1.68% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 3.3B | SAR 23B | SAR 162.98 | 1.07% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | SAR 5.7B | SAR 43.7B | SAR 225.77 | 2.87% up | 11% up | ||
| 29 | InsmedINSM · Health Care | SAR 5.7B | SAR 98.8B | SAR 450.16 | 1.52% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | SAR 6.1B | SAR 66.5B | SAR 1,014.50 | 0.27% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | SAR 7.8B | SAR 26.8B | SAR 192.28 | 0.76% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 7.9B | SAR 46.9B | SAR 56.21 | 1.32% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | SAR 11.3B | SAR 57B | SAR 292.40 | 1.50% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SAR 11.4B | SAR 17B | SAR 102.33 | 1.19% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | SAR 11.6B | SAR 19B | SAR 227.12 | 0.31% up | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | SAR 13.8B | SAR 28.3B | SAR 81.10 | 2.37% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | SAR 14.4B | SAR 173.3B | SAR 1,517.54 | 2.10% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | SAR 15.7B | SAR 77B | SAR 575.12 | 2.03% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | SAR 25.5B | SAR 49.5B | SAR 99.10 | 2.21% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | SAR 26.2B | SAR 508.7B | SAR 2,006.48 | 0.13% up | 27% up | ||
| 41 | GenmabGMAB · Health Care | SAR 26.4B | SAR 119B | SAR 192.99 | 0.98% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 27.5B | SAR 58.7B | SAR 914.38 | 1.27% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | SAR 34.9B | SAR 370.8B | SAR 3,584.79 | 0.22% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | SAR 37.2B | SAR 147.8B | SAR 257.09 | 0.20% down | 78% up | ||
| 45 | ZoetisZTS · Health Care | SAR 45.5B | SAR 127.9B | SAR 314.88 | 0.56% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | SAR 50.4B | SAR 21.8B | SAR 32.09 | 0.87% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | SAR 84.3B | SAR 89.2B | SAR 77.78 | 1.39% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 123.2B | SAR 185.7B | SAR 159.12 | 0.47% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | SAR 127.3B | SAR 676.5B | SAR 390.61 | 0.55% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | SAR 189.8B | SAR 256.2B | SAR 80.18 | 1.22% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | SAR 194.2B | SAR 657.2B | SAR 149.12 | 2.32% down | 17% down | ||
| 52 | GSKGSK · Health Care | SAR 224.9B | SAR 367.4B | SAR 183.31 | 0.75% down | 6% up | ||
| 53 | SanofiSNY · Health Care | SAR 229.3B | SAR 425.9B | SAR 177.38 | 0.50% down | 4% down | ||
| 54 | NovartisNVS · Health Care | SAR 241.6B | SAR 1.11T | SAR 586.32 | 1.77% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | SAR 245.1B | SAR 1.04T | SAR 671.67 | 1.76% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | SAR 268.3B | SAR 459.3B | SAR 224.68 | 2.36% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | SAR 315.8B | SAR 1.29T | SAR 523.60 | 2.64% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | SAR 322.4B | SAR 4.64T | SAR 5,211.41 | 1.85% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | SAR 441.4B | SAR 2.48T | SAR 1,032.24 | 1.26% down | 38% up | ||
| 60 | PfizerPFE · Health Care | SAR 455.3B | SAR 602.4B | SAR 105.68 | 1.04% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | SAR 514.6B | SAR 1.91T | SAR 1,081.84 | 1.50% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (SAR 34.3M), Belite Bio (SAR 37.8M) and Oruka Therapeutics (SAR 62.6M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of SAR 19.08T as of 18 Nov 2026, 16:06 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.